EP0683675A4 - Humane monoklonale antikörper gegen cytomegalovirus. - Google Patents

Humane monoklonale antikörper gegen cytomegalovirus.

Info

Publication number: EP0683675A4
Authority: EP; European Patent Office
Prior art keywords: cytomegalovirus; monoclonal antibodies; human monoclonal; human; antibodies
Prior art date: 1993-01-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP94908670A

Other languages

English (en)

French (fr)

Other versions

EP0683675A1 (de

Inventor

Lars G Ostberg

Paul Nadler

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Novartis Pharmaceuticals Corp

Original Assignee

Sandoz Pharmaceuticals Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-01-28

Filing date

1994-01-28

Publication date

1997-05-21

1994-01-28 Application filed by Sandoz Pharmaceuticals Corp filed Critical Sandoz Pharmaceuticals Corp

1995-11-29 Publication of EP0683675A1 publication Critical patent/EP0683675A1/de

1997-05-21 Publication of EP0683675A4 publication Critical patent/EP0683675A4/de

Status Withdrawn legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—DNA viruses
- C07K16/085—Orthoherpesviridae (F), e.g. pseudorabies virus or Epstein-Barr virus
- C07K16/089—Cytomegalovirus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Virology (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Tropical Medicine & Parasitology (AREA)
Oncology (AREA)
Mycology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Epidemiology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Microbiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
AIDS & HIV (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

EP94908670A 1993-01-28 1994-01-28 Humane monoklonale antikörper gegen cytomegalovirus. Withdrawn EP0683675A4 (de)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US1022893A	1993-01-28	1993-01-28
US7380893A	1993-06-09	1993-06-09
US73808		1993-06-09
PCT/US1994/001068 WO1994016730A1 (en)	1993-01-28	1994-01-28	Human monoclonal antibodies to cytomegalovirus
US10228		1996-01-19

Publications (2)

Publication Number	Publication Date
EP0683675A1 EP0683675A1 (de)	1995-11-29
EP0683675A4 true EP0683675A4 (de)	1997-05-21

Family

ID=26680936

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP94908670A Withdrawn EP0683675A4 (de)	1993-01-28	1994-01-28	Humane monoklonale antikörper gegen cytomegalovirus.

Country Status (5)

Country	Link
EP (1)	EP0683675A4 (de)
JP (1)	JPH08506325A (de)
AU (1)	AU695584B2 (de)
CA (1)	CA2153790A1 (de)
WO (1)	WO1994016730A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5750106A (en) *	1993-01-28	1998-05-12	Novartis Ag	Human monoclonal antibodies to cytomegalovirus
US20020004046A1 (en) *	2000-05-03	2002-01-10	Johnson Leslie S.	Combination therapy of respiratory diseases using antibodies
WO2007094423A1 (ja) *	2006-02-15	2007-08-23	Evec Incorporated	ヒトサイトメガロウイルスに結合するヒトのモノクローナル抗体並びにその抗原結合部分
US7947274B2 (en)	2007-01-04	2011-05-24	Humabs, LLC.	Human cytomegalovirus neutralising antibodies and use thereof
GB0700133D0 (en)	2007-01-04	2007-02-14	Humabs Llc	Human cytomegalovirus neutralising antibodies and use thereof
EP2173771A1 (de)	2007-07-04	2010-04-14	Ribovax Biotechnologies SA	Antikörper gegen das humane cytomegalie-virus (hcmv)
EP3156069B8 (de)	2008-06-20	2020-10-21	Duke University	Zusammensetzungen, verfahren und kits zur auslösung einer immunreaktion
DK2352759T3 (en)	2008-07-16	2017-12-18	Inst Res Biomedicine	ANTIBODIES THAT NEUTRALIZE HUMAN CYTOMEGALOVIRUS AND USE THEREOF
KR101390015B1 (ko)	2009-04-01	2014-04-29	에베크 인코포레이티드	인간 사이토메갈로바이러스 ｇＢ 당단백질의 ＡＤ1 영역에 존재하는 특정한 불연속 에피토프에 결합하는 모노클로날 항체 및 그의 항원 결합성 단편
WO2012047732A2 (en) *	2010-09-29	2012-04-12	Genentech, Inc.	Antibody compositions and methods of use
EP3728316B1 (de)	2017-12-19	2025-02-26	invoX Pharma Limited	Fc-bindungsfragmente mit einer pd-l1 antigen-bindungsstelle
PT3820569T (pt)	2018-07-12	2025-01-14	Invox Pharma Ltd	Moléculas de anticorpo que se ligam a pd-l1 e cd137
CN116135971B (zh) *	2023-03-30	2025-03-14	同路生物制药有限公司	一种人巨细胞病毒的培养方法

1994
- 1994-01-28 JP JP6517375A patent/JPH08506325A/ja active Pending
- 1994-01-28 AU AU61677/94A patent/AU695584B2/en not_active Ceased
- 1994-01-28 EP EP94908670A patent/EP0683675A4/de not_active Withdrawn
- 1994-01-28 CA CA002153790A patent/CA2153790A1/en not_active Abandoned
- 1994-01-28 WO PCT/US1994/001068 patent/WO1994016730A1/en not_active Ceased

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DUMMER: "CYTOMEGALOVIRUS INFECTION AFTER LIVER TRANSPLANTATION: CLINICAL MANIFESTATIONS AND STRATEGIES FOR PREVENTION", REVIEWS OF INFECTIOUS DISEASES, vol. 12, no. S7, 1990, pages S767 - S775, XP000647578 *
NOKTA ET AL: "HUMAN MONOCLONAL ANTI CYTOMEGALOVIRUS (CMV) ANTIBODY (MSL-109): ENHANCEMENT OF IN VITRO FOSCARNET INDUCED INHIBITION OF CMV REPLICATION", ANTIVIRAL RESEARCH, vol. 17, no. S1, 1992, pages 97, XP002027786 *
See also references of WO9416730A1 *
STRATTA ET AL: "CYTOMEGALOVIRUS INFECTION AND DISEASE AFTER LIVER TRANSPLANTATION. AN OVERVIEW", DIGESTIVE DISEASES AND SCIENCES, vol. 37, 1992, pages 673 - 688, XP000647567 *

Also Published As

Publication number	Publication date
EP0683675A1 (de)	1995-11-29
JPH08506325A (ja)	1996-07-09
WO1994016730A1 (en)	1994-08-04
AU695584B2 (en)	1998-08-20
AU6167794A (en)	1994-08-15
CA2153790A1 (en)	1994-08-04

Legal Events

Date	Code	Title	Description
1995-10-13	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
1995-11-29	17P	Request for examination filed	Effective date: 19950824
1995-11-29	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
1997-05-21	A4	Supplementary search report drawn up and despatched	Effective date: 19970407
1997-05-21	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
1999-05-19	17Q	First examination report despatched	Effective date: 19990407
2002-09-13	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2002-10-30	18D	Application deemed to be withdrawn	Effective date: 20020409

Publication	Publication Date	Title
AU1289795A (en)	1995-06-06	Monoclonal antibodies specific for human interleukin-5
PL311926A1 (en)	1996-06-24	Anti-alphav-integrinic monoclonal antibodies
ZA949341B (en)	1996-05-24	Humanized antibodies and uses thereof
IL130864A0 (en)	2001-01-28	Monoclonal antibodies to human cd6
AU4618193A (en)	1994-03-17	Humanized antibodies
GB9412166D0 (en)	1994-08-10	Retargetting antibodies
EP0683675A4 (de)	1997-05-21	Humane monoklonale antikörper gegen cytomegalovirus.
EP0578515A3 (de)	1995-05-10	Humanisierte, monoklonale Antikörper.
EP0580859A4 (en)	1994-09-14	Anti-eda monoclonal antibody
IL90017A0 (en)	1989-12-15	Monoclonal antibodies
AU6155896A (en)	1996-12-30	Humanized antibodies to e-selectin
ZA898777B (en)	1990-12-28	Monoclonal antibodies
IL92232A0 (en)	1990-07-26	Anti-fucosylceramide monoclonal antibody
EP0506523A3 (en)	1993-10-20	Monoclonal antibodies
ZA89258B (en)	1989-10-25	Monoclonal antibodies
AU6777594A (en)	1994-11-21	Human monoclonal antibodies to human cytomegalovirus, and methods therefor
GB8927389D0 (en)	1990-01-31	Monoclonal antibodies
EP0654532A4 (de)	1996-04-24	Monoklonale antikörper gegen antimucoglykoprotein.
GB8820036D0 (en)	1988-09-28	Monoclonal antibodies
ZA912136B (en)	1992-11-25	Anti-oncostatin m monoclonal antibodies
EP0336441A3 (en)	1990-05-16	Anti-cpbii monoclonal antibody
EP0668923A4 (de)	1996-06-26	Monoklonaler antikörper.
GB9309884D0 (en)	1993-06-23	Antibodies
GB9320508D0 (en)	1993-11-24	Antibodies
GB9212074D0 (en)	1992-07-22	Monoclonal antibody